SteadyMD Review

SteadyMD — Provider Profile

Overview

SteadyMD is a direct primary care (DPC) telehealth platform founded in 2018. The core product is a monthly subscription that gives patients an ongoing relationship with a dedicated primary care physician — one doctor, seen consistently over time, who builds a full medical picture rather than reviewing a questionnaire. Patients interact with the same physician across visits, which allows for informed long-term decisions rather than episodic prescription management.

GLP-1 medications are available through SteadyMD, but this is not a GLP-1-first platform. Weight management is one component of comprehensive primary care. A SteadyMD physician might prescribe semaglutide or tirzepatide, but they will also manage hypertension, order labs, address mental health concerns, and handle the full range of primary care needs. This breadth is exactly what distinguishes SteadyMD from specialized GLP-1 telehealth platforms and is the primary reason a patient would choose it.

The DPC model has specific advantages for weight management specifically: longitudinal care allows better medication titration, the physician sees how weight changes interact with other conditions over time, and there's no incentive to continue prescribing a medication that isn't working. In the current GLP-1 telehealth landscape, where some platforms have financial incentives to keep patients on subscriptions regardless of outcomes, the DPC model offers a meaningful structural counterbalance.

Medications Offered

• GLP-1 receptor agonists (semaglutide, tirzepatide) prescribed as clinically appropriate within ongoing primary care relationship
• Full primary care formulary — weight management medications are one part of a comprehensive scope
• Medication costs are separate from the DPC subscription fee

Note: Compounded semaglutide lost its FDA shortage exemption in February 2025. Compounded tirzepatide faces an FDA 503B enforcement deadline in April 2026. SteadyMD physicians prescribe within FDA guidelines; patients should confirm medication specifics directly with their assigned physician. Brand-name GLP-1 medication costs (Wegovy, Zepbound) are not included in the DPC subscription and must be covered through pharmacy benefits or paid out of pocket.

Pricing

Pricing is approximate as of April 2026. SteadyMD's subscription covers the physician relationship and consultations; it does not include prescription drug costs. Brand-name semaglutide (Wegovy) and tirzepatide (Zepbound) carry list prices of $1,000–$1,400/month without insurance, making pharmacy coverage the primary cost variable. Verify current plan pricing at steadymd.com.

States Served

SteadyMD operates across most U.S. states. Physician availability may vary by state due to licensure requirements. Confirm availability in your state at steadymd.com.

Insurance

• DPC subscription is typically not billed to insurance (this is the defining feature of DPC)
• HSA/FSA funds may be applicable for subscription fees — confirm with your plan administrator
• Medication prescriptions written by SteadyMD physicians can be submitted to your pharmacy benefits as normal
• Lab work ordered through SteadyMD may be covered by your health insurance

Consultation Process

Model: Ongoing relationship with dedicated primary care physician via video and asynchronous messaging

1. Choose a physician from SteadyMD's available providers (specialty interests, background visible on profiles)
2. Onboarding intake: medical history, current medications, health goals
3. Initial video consultation with your dedicated PCP to establish care and discuss priorities
4. GLP-1 candidacy evaluated as part of comprehensive health assessment — not a standalone questionnaire
5. Ongoing async messaging with your physician for routine questions and medication adjustments
6. Scheduled video follow-ups for titration reviews and care updates
7. Physician orders labs and coordinates with specialists as needed

Pros

• Ongoing relationship with a single dedicated PCP — not episodic, rotating care
• GLP-1 prescribing is embedded in comprehensive primary care, with full context about the patient's health
• DPC model removes volume-based incentives that can distort prescribing decisions in subscription telehealth
• Better longitudinal management of medication titration and side effects over time
• Single platform for all primary care needs — no need for multiple specialized telehealth subscriptions
• Physicians can order labs and manage comorbidities alongside weight management

Cons

• Monthly subscription cost plus separate medication costs creates higher total expense than GLP-1-only platforms if those platforms cover some medication costs
• Not the fastest path to a GLP-1 prescription — appropriate evaluation takes time
• No built-in pharmacy benefit or medication discount program as part of the platform
• DPC subscription is not reimbursed by traditional insurance, which may feel redundant to patients with existing coverage
• Less specialized weight management expertise than obesity medicine-specific platforms

Best For

SteadyMD is best suited for patients who want a single primary care physician to manage their health comprehensively — including weight management — rather than managing multiple separate telehealth subscriptions for different conditions. It is a strong choice for patients with multiple health conditions where weight interacts with other issues (hypertension, prediabetes, mental health), for patients who have had poor experiences with episodic care, and for anyone who values a real, ongoing physician relationship as the foundation of their healthcare rather than a tool for obtaining specific prescriptions.

Editorial Verdict

SteadyMD occupies a distinct position in the telehealth market. Most GLP-1 platforms are essentially prescription-delivery services with monitoring attached. SteadyMD is a primary care practice that happens to operate entirely remotely. This is a meaningful clinical difference, not a marketing distinction. Patients who use SteadyMD for weight management are getting their GLP-1 prescriptions managed by a physician who also knows their blood pressure history, their sleep patterns, and their other medications. That context matters for safe, effective prescribing.

The financial calculus is worth thinking through carefully. A DPC subscription of $100–$150 per month, layered on top of brand-name GLP-1 costs of $1,000+ per month without coverage, makes SteadyMD an expensive combination for uninsured or underinsured patients. If your pharmacy benefits cover GLP-1 medications and you want a physician to manage your overall primary care alongside weight management, SteadyMD makes financial sense. If you're paying entirely out of pocket and only want a GLP-1 prescription, a more focused platform may be cheaper.

For patients who want real healthcare rather than a medication subscription, SteadyMD is one of the few telehealth platforms built around that goal. The DPC structure, the longitudinal physician relationship, and the comprehensive scope all serve patients best — even if they make the platform less convenient for anyone who wants a fast, frictionless experience.

Related Content

• How Much Does Semaglutide Cost?
• How Much Does Tirzepatide Cost?
• Who Qualifies for GLP-1 Medications?